Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina Dibenedetto

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Research Square|May 25, 2026
An InDel Genomic Variant within a Bifunctional Super-Enhancer for LINC00636 and CD47 Regulation in Breast CancerCarolina Dibenedetto, Amelia Tsark, Daniza Acenas, et al.
Research Square|April 16, 2025
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeDenise Paula Muñoz, Camila D Arcuschin, Kamin Kahrizi, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4 <sup>+</sup> cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeCamila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman, et al.
Cellular and Molecular Life Sciences : CMLS|November 13, 2025
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4<sup>+</sup> cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeCamila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Research Square|May 25, 2026
An InDel Genomic Variant within a Bifunctional Super-Enhancer for LINC00636 and CD47 Regulation in Breast CancerCarolina Dibenedetto, Amelia Tsark, Daniza Acenas, et al.
Research Square|April 16, 2025
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeDenise Paula Muñoz, Camila D Arcuschin, Kamin Kahrizi, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4 <sup>+</sup> cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeCamila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman, et al.
Cellular and Molecular Life Sciences : CMLS|November 13, 2025
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4<sup>+</sup> cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeCamila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman, et al.
Pageof 1